Evidence map›Paper›PMID 42824238›Full record

ReviewIndian journal of orthopaedics2026

Posterior Cruciate Ligament Reconstruction in Elite Athletes: A Narrative Review.

Darby Amelia Elliott, Chinmay Madhukar Gupte

Abstract readReview
In one paragraph

Review in Indian journal of orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Darby Amelia ElliottDepartment of Orthopaedic Surgery and Sports Medicine, London, UK.ORCID 0009-0002-8914-933X
Chinmay Madhukar GupteDepartment of Orthopaedic Surgery and Sports Medicine, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Posterior cruciate ligament (PCL) injuries are uncommon in sport but may be career-defining for elite athletes. Controversy remains regarding indications for reconstruction, optimal techniques and the role of braced non-operative care. This narrative review summarises evidence on operative and non-operative management of PCL injuries in elite athletes, focusing on return-to-play (RTP), graft selection, reconstruction strategy and elite-specific considerations. Methods: A narrative review was conducted in PubMed and Embase (inception-April 2025) with reference list screening. Clinical studies reporting return-to-play outcomes after operative or non-operative management of isolated PCL injuries and PCL-based MLKIs in athletic cohorts were prioritised; 51 studies were included, and heterogeneity precluded meta-analysis. Results: Isolated PCL injuries in elite footballers are rare, whereas PCL-based multi-ligament knee injuries (MLKIs) are more common in collision sports. Early dynamic bracing with quadriceps-focused rehabilitation enables > 90% RTP in selected acute isolated grade II-III tears in high-level athletic cohorts (Level III evidence). For chronic instability or MLKIs, anatomic single-bundle reconstruction remains common, with double-bundle and tibial inlay approaches offering biomechanical but limited clinical advantages. Modern elite MLKI cohorts report 80-90% RTP, though full return-to-performance is less frequent. Conclusions: Management of elite PCL injuries requires individualised, sport-specific decision-making that balances biological healing with performance demands. High-quality, sport-specific outcome data remain limited.Level of EvidenceLevel V, narrative review.

Indexed as

Dynamic bracingElite athleteMulti-ligament knee injuryPosterior cruciate ligamentReconstructionReturn to play

Identifiers

PMID42824238
PMCPMC13627502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.